266 related articles for article (PubMed ID: 33938268)
1. An independent, replicable, functional and significant risk variant block at intron 3 of
Wang Z; Chen W; Cao Y; Dou Y; Fu Y; Zhang Y; Luo X; Kang L; Liu N; Shi YS; Li CR; Xu Y; Guo X; Luo X
Aust N Z J Psychiatry; 2022 Apr; 56(4):385-397. PubMed ID: 33938268
[TBL] [Abstract][Full Text] [Related]
2. A novel risk variant block across introns 36-45 of CACNA1C for schizophrenia: a cohort-wise replication and cerebral region-wide validation study.
Guo X; Wang S; Lin X; Wang Z; Dou Y; Cao Y; Zhang Y; Luo X; Kang L; Yu T; Wang Z; Tan Y; Gao S; Zheng H; Zhao F; Wang H; Wang K; Xie F; Chen W; Luo X
Psychiatr Genet; 2023 Oct; 33(5):182-190. PubMed ID: 37706495
[TBL] [Abstract][Full Text] [Related]
3. A significant, functional and replicable risk KTN1 variant block for schizophrenia.
Mao Q; Lin X; Yin Q; Liu P; Zhang Y; Qu S; Xu J; Cheng W; Luo X; Kang L; Taximaimaiti R; Zheng C; Zhang H; Wang X; Ren H; Cao Y; Lin J; Luo X
Sci Rep; 2023 Mar; 13(1):3890. PubMed ID: 36890161
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic Association of CACNA1C Variants With Neuropsychiatric Disorders.
Wang Z; Lin X; Luo X; Xiao J; Zhang Y; Xu J; Wang S; Zhao F; Wang H; Zheng H; Zhang W; Lin C; Tan Z; Cao L; Wang Z; Tan Y; Chen W; Cao Y; Guo X; Pittenger C; Luo X
Schizophr Bull; 2023 Sep; 49(5):1174-1184. PubMed ID: 37306960
[TBL] [Abstract][Full Text] [Related]
5. Functional Characterization of Schizophrenia-Associated Variation in CACNA1C.
Eckart N; Song Q; Yang R; Wang R; Zhu H; McCallion AS; Avramopoulos D
PLoS One; 2016; 11(6):e0157086. PubMed ID: 27276213
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in CACNA1C affects brain circuitries related to mental illness.
Bigos KL; Mattay VS; Callicott JH; Straub RE; Vakkalanka R; Kolachana B; Hyde TM; Lipska BK; Kleinman JE; Weinberger DR
Arch Gen Psychiatry; 2010 Sep; 67(9):939-45. PubMed ID: 20819988
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC.
Hamshere ML; Walters JT; Smith R; Richards AL; Green E; Grozeva D; Jones I; Forty L; Jones L; Gordon-Smith K; Riley B; O'Neill FA; Kendler KS; Sklar P; Purcell S; Kranz J; ; ; ; Morris D; Gill M; Holmans P; Craddock N; Corvin A; Owen MJ; O'Donovan MC
Mol Psychiatry; 2013 Jun; 18(6):708-12. PubMed ID: 22614287
[TBL] [Abstract][Full Text] [Related]
8. CACNA1C hypermethylation is associated with bipolar disorder.
Starnawska A; Demontis D; Pen A; Hedemand A; Nielsen AL; Staunstrup NH; Grove J; Als TD; Jarram A; O'Brien NL; Mors O; McQuillin A; Børglum AD; Nyegaard M
Transl Psychiatry; 2016 Jun; 6(6):e831. PubMed ID: 27271857
[TBL] [Abstract][Full Text] [Related]
9. CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls.
Tesli M; Skatun KC; Ousdal OT; Brown AA; Thoresen C; Agartz I; Melle I; Djurovic S; Jensen J; Andreassen OA
PLoS One; 2013; 8(2):e56970. PubMed ID: 23437284
[TBL] [Abstract][Full Text] [Related]
10. Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood.
Dedic N; Pöhlmann ML; Richter JS; Mehta D; Czamara D; Metzger MW; Dine J; Bedenk BT; Hartmann J; Wagner KV; Jurik A; Almli LM; Lori A; Moosmang S; Hofmann F; Wotjak CT; Rammes G; Eder M; Chen A; Ressler KJ; Wurst W; Schmidt MV; Binder EB; Deussing JM
Mol Psychiatry; 2018 Mar; 23(3):533-543. PubMed ID: 28696432
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a Human-Specific Tandem Repeat Associated with Bipolar Disorder and Schizophrenia.
Song JHT; Lowe CB; Kingsley DM
Am J Hum Genet; 2018 Sep; 103(3):421-430. PubMed ID: 30100087
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working Memory.
Cosgrove D; Mothersill O; Kendall K; Konte B; Harold D; Giegling I; Hartmann A; Richards A; Mantripragada K; ; Owen MJ; O'Donovan MC; Gill M; Rujescu D; Walters J; Corvin A; Morris DW; Donohoe G
Neuropsychopharmacology; 2017 Dec; 42(13):2612-2622. PubMed ID: 28607492
[TBL] [Abstract][Full Text] [Related]
13. Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals.
Hori H; Yamamoto N; Fujii T; Teraishi T; Sasayama D; Matsuo J; Kawamoto Y; Kinoshita Y; Ota M; Hattori K; Tatsumi M; Arima K; Kunugi H
Sci Rep; 2012; 2():634. PubMed ID: 22957138
[TBL] [Abstract][Full Text] [Related]
14. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.
Psychiatric GWAS Consortium Bipolar Disorder Working Group
Nat Genet; 2011 Sep; 43(10):977-83. PubMed ID: 21926972
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned.
Wray NR; Pergadia ML; Blackwood DH; Penninx BW; Gordon SD; Nyholt DR; Ripke S; MacIntyre DJ; McGhee KA; Maclean AW; Smit JH; Hottenga JJ; Willemsen G; Middeldorp CM; de Geus EJ; Lewis CM; McGuffin P; Hickie IB; van den Oord EJ; Liu JZ; Macgregor S; McEvoy BP; Byrne EM; Medland SE; Statham DJ; Henders AK; Heath AC; Montgomery GW; Martin NG; Boomsma DI; Madden PA; Sullivan PF
Mol Psychiatry; 2012 Jan; 17(1):36-48. PubMed ID: 21042317
[TBL] [Abstract][Full Text] [Related]
16. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia.
Almodóvar-Payá C; Guardiola-Ripoll M; Giralt-López M; Oscoz-Irurozqui M; Canales-Rodríguez EJ; Madre M; Soler-Vidal J; Ramiro N; Callado LF; Arias B; Gallego C; Pomarol-Clotet E; Fatjó-Vilas M
Brain Struct Funct; 2024 Jun; 229(5):1299-1315. PubMed ID: 38720004
[TBL] [Abstract][Full Text] [Related]
17. Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology.
Billingsley KJ; Manca M; Gianfrancesco O; Collier DA; Sharp H; Bubb VJ; Quinn JP
Schizophr Res; 2018 Sep; 199():168-175. PubMed ID: 29501388
[TBL] [Abstract][Full Text] [Related]
18. A role for noncoding variation in schizophrenia.
Roussos P; Mitchell AC; Voloudakis G; Fullard JF; Pothula VM; Tsang J; Stahl EA; Georgakopoulos A; Ruderfer DM; Charney A; Okada Y; Siminovitch KA; Worthington J; Padyukov L; Klareskog L; Gregersen PK; Plenge RM; Raychaudhuri S; Fromer M; Purcell SM; Brennand KJ; Robakis NK; Schadt EE; Akbarian S; Sklar P
Cell Rep; 2014 Nov; 9(4):1417-29. PubMed ID: 25453756
[TBL] [Abstract][Full Text] [Related]
19. Effect of rs1108580 of DBH and rs1006737 of CACNA1C on Cognition and Tardive Dyskinesia in a North Indian Schizophrenia Cohort.
Punchaichira TJ; Kukshal P; Bhatia T; Deshpande SN; Thelma BK
Mol Neurobiol; 2023 Dec; 60(12):6826-6839. PubMed ID: 37493923
[TBL] [Abstract][Full Text] [Related]
20. Variants in calcium voltage-gated channel subunit Alpha1 C-gene (CACNA1C) are associated with sleep latency in infants.
Kantojärvi K; Liuhanen J; Saarenpää-Heikkilä O; Satomaa AL; Kylliäinen A; Pölkki P; Jaatela J; Toivola A; Milani L; Himanen SL; Porkka-Heiskanen T; Paavonen J; Paunio T
PLoS One; 2017; 12(8):e0180652. PubMed ID: 28792954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
